A two-way ANOVA showed that the experimental condition of MS resulted in significantly higher cytokine levels compared to the groups that did not undergo MS and was treated with saline (IL-1β: F(1, 28) = 14.36, p = 0.0006; IL-6: F(1, 28) = 12.21, p = 0.0012; TNF-α: F(1, 28) = 13.47, p = 0.0008). The gene discussed is IL1B; the disease is myeloid sarcoma.